vs
Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and HARROW, INC. (HROW). Click either name above to swap in a different company.
COASTAL FINANCIAL CORP is the larger business by last-quarter revenue ($138.0M vs $89.1M, roughly 1.5× HARROW, INC.). On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs -5.8%). COASTAL FINANCIAL CORP produced more free cash flow last quarter ($246.1M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -3.6%).
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
CCB vs HROW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $138.0M | $89.1M |
| Net Profit | — | $6.6M |
| Gross Margin | — | 79.3% |
| Operating Margin | 12.4% | 17.5% |
| Net Margin | — | 7.4% |
| Revenue YoY | -5.8% | 33.3% |
| Net Profit YoY | — | -2.2% |
| EPS (diluted) | $0.84 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $138.0M | $89.1M | ||
| Q3 25 | $144.7M | $71.6M | ||
| Q2 25 | $119.4M | $63.7M | ||
| Q1 25 | $139.5M | $47.8M | ||
| Q4 24 | $146.5M | $66.8M | ||
| Q3 24 | $151.1M | $49.3M | ||
| Q2 24 | $135.3M | $48.9M | ||
| Q1 24 | $148.4M | $34.6M |
| Q4 25 | — | $6.6M | ||
| Q3 25 | $13.6M | $1.0M | ||
| Q2 25 | $11.0M | $5.0M | ||
| Q1 25 | $9.7M | $-17.8M | ||
| Q4 24 | — | $6.8M | ||
| Q3 24 | $13.5M | $-4.2M | ||
| Q2 24 | $11.6M | $-6.5M | ||
| Q1 24 | $6.8M | $-13.6M |
| Q4 25 | — | 79.3% | ||
| Q3 25 | — | 75.3% | ||
| Q2 25 | — | 74.5% | ||
| Q1 25 | — | 67.5% | ||
| Q4 24 | — | 78.8% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 74.4% | ||
| Q1 24 | — | 69.5% |
| Q4 25 | 12.4% | 17.5% | ||
| Q3 25 | 12.4% | 20.6% | ||
| Q2 25 | 12.0% | 17.9% | ||
| Q1 25 | 8.4% | -23.5% | ||
| Q4 24 | 11.7% | 19.3% | ||
| Q3 24 | 10.8% | 2.7% | ||
| Q2 24 | 11.1% | 3.1% | ||
| Q1 24 | 5.9% | -20.0% |
| Q4 25 | — | 7.4% | ||
| Q3 25 | 9.4% | 1.4% | ||
| Q2 25 | 9.2% | 7.8% | ||
| Q1 25 | 7.0% | -37.2% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | 8.9% | -8.6% | ||
| Q2 24 | 8.6% | -13.2% | ||
| Q1 24 | 4.6% | -39.2% |
| Q4 25 | $0.84 | $0.20 | ||
| Q3 25 | $0.88 | $0.03 | ||
| Q2 25 | $0.71 | $0.13 | ||
| Q1 25 | $0.63 | $-0.50 | ||
| Q4 24 | $0.95 | $0.19 | ||
| Q3 24 | $0.97 | $-0.12 | ||
| Q2 24 | $0.84 | $-0.18 | ||
| Q1 24 | $0.50 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $72.9M |
| Total DebtLower is stronger | — | $250.0M |
| Stockholders' EquityBook value | $491.0M | $52.4M |
| Total Assets | $4.7B | $399.5M |
| Debt / EquityLower = less leverage | — | 4.77× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $72.9M | ||
| Q3 25 | — | $74.3M | ||
| Q2 25 | — | $53.0M | ||
| Q1 25 | — | $66.7M | ||
| Q4 24 | — | $47.2M | ||
| Q3 24 | — | $72.6M | ||
| Q2 24 | — | $71.0M | ||
| Q1 24 | — | $76.0M |
| Q4 25 | — | $250.0M | ||
| Q3 25 | — | $347.2M | ||
| Q2 25 | — | $250.6M | ||
| Q1 25 | — | $256.9M | ||
| Q4 24 | — | $262.7M | ||
| Q3 24 | — | $230.7M | ||
| Q2 24 | — | $236.3M | ||
| Q1 24 | — | $243.4M |
| Q4 25 | $491.0M | $52.4M | ||
| Q3 25 | $475.3M | $47.0M | ||
| Q2 25 | $461.7M | $49.7M | ||
| Q1 25 | $449.9M | $56.5M | ||
| Q4 24 | $438.7M | $69.7M | ||
| Q3 24 | $331.9M | $58.0M | ||
| Q2 24 | $316.7M | $58.5M | ||
| Q1 24 | $303.7M | $60.6M |
| Q4 25 | $4.7B | $399.5M | ||
| Q3 25 | $4.6B | $363.1M | ||
| Q2 25 | $4.5B | $345.0M | ||
| Q1 25 | $4.3B | $364.2M | ||
| Q4 24 | $4.1B | $389.0M | ||
| Q3 24 | $4.1B | $351.5M | ||
| Q2 24 | $4.0B | $306.6M | ||
| Q1 24 | $3.9B | $295.5M |
| Q4 25 | — | 4.77× | ||
| Q3 25 | — | 7.39× | ||
| Q2 25 | — | 5.05× | ||
| Q1 25 | — | 4.55× | ||
| Q4 24 | — | 3.77× | ||
| Q3 24 | — | 3.98× | ||
| Q2 24 | — | 4.04× | ||
| Q1 24 | — | 4.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $254.6M | $8.4M |
| Free Cash FlowOCF − Capex | $246.1M | $8.1M |
| FCF MarginFCF / Revenue | 178.3% | 9.1% |
| Capex IntensityCapex / Revenue | 6.1% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 1.27× |
| TTM Free Cash FlowTrailing 4 quarters | $436.4M | $43.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $254.6M | $8.4M | ||
| Q3 25 | $59.0M | $16.6M | ||
| Q2 25 | $66.0M | $-803.0K | ||
| Q1 25 | $71.7M | $19.7M | ||
| Q4 24 | $259.8M | $-17.8M | ||
| Q3 24 | $62.6M | $3.0M | ||
| Q2 24 | $72.1M | $-2.7M | ||
| Q1 24 | $56.8M | $-4.6M |
| Q4 25 | $246.1M | $8.1M | ||
| Q3 25 | $57.4M | $16.4M | ||
| Q2 25 | $64.0M | $-969.0K | ||
| Q1 25 | $68.9M | $19.5M | ||
| Q4 24 | $249.9M | $-18.3M | ||
| Q3 24 | $60.2M | $2.3M | ||
| Q2 24 | $69.5M | $-3.1M | ||
| Q1 24 | $55.0M | $-4.7M |
| Q4 25 | 178.3% | 9.1% | ||
| Q3 25 | 39.7% | 22.9% | ||
| Q2 25 | 53.6% | -1.5% | ||
| Q1 25 | 49.4% | 40.8% | ||
| Q4 24 | 170.6% | -27.4% | ||
| Q3 24 | 39.8% | 4.8% | ||
| Q2 24 | 51.3% | -6.3% | ||
| Q1 24 | 37.1% | -13.6% |
| Q4 25 | 6.1% | 0.4% | ||
| Q3 25 | 1.2% | 0.3% | ||
| Q2 25 | 1.7% | 0.3% | ||
| Q1 25 | 2.0% | 0.4% | ||
| Q4 24 | 6.8% | 0.8% | ||
| Q3 24 | 1.6% | 1.2% | ||
| Q2 24 | 1.9% | 0.7% | ||
| Q1 24 | 1.2% | 0.3% |
| Q4 25 | — | 1.27× | ||
| Q3 25 | 4.34× | 16.26× | ||
| Q2 25 | 5.99× | -0.16× | ||
| Q1 25 | 7.37× | — | ||
| Q4 24 | — | -2.62× | ||
| Q3 24 | 4.65× | — | ||
| Q2 24 | 6.22× | — | ||
| Q1 24 | 8.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCB
| Other | $74.7M | 54% |
| Baa S Credit Enhancements | $47.3M | 34% |
| Baa S Program Income | $8.4M | 6% |
| Transaction Fees | $4.9M | 4% |
| Servicing And Other Baa S Fees | $1.6M | 1% |
| Baa S Fraud Enhancements | $1.1M | 1% |
HROW
Segment breakdown not available.
